Spotlight
Clinical
CME/CE
Dr. Halpern discusses direct-to-consumer testosterone therapy platforms
“What we found is that the majority of these companies…offered our ‘secret shopper’ testosterone therapy,” says Joshua A. Halpern, MD, MS.
In this video, Joshua A. Halpern, MD, MS, discusses the background and notable findings from the JAMA Internal Medicine study, “Guideline-Discordant Care Among Direct-to-Consumer Testosterone Therapy Platforms,” for which he served as senior author. Halpern is an assistant professor of urology at Northwestern University Feinberg School of Medicine in Chicago, Illinois.
Related Videos
Related Content
